---
category: news
title: "Lantheus and Progenics Reschedule Their Respective Special Meetings of Stockholders for Proposed Merger"
excerpt: "About Progenics Progenics is an oncology company focused on the development and commercialization of innovative targeted medicines and artificial intelligence to find ... who require systemic anticancer therapy; and oral and subcutaneous formulations of RELISTOR Â® (methylnaltrexone bromide) for the treatment of opioid-induced constipation ..."
publishedDateTime: 2020-04-02T12:30:00Z
webUrl: "https://www.businesswire.com/news/home/20200402005433/en/Lantheus-Progenics-Reschedule-Respective-Special-Meetings-Stockholders"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "wgHU/UfqFpzwGBWNXVxhDrUC5LfYxjeKEqsy0y3Jw8NLQMB9jGzGA4n3kapwuBunFAFj1vffxK8rDeBpFWab+PIb8eC4pgrd7wPOK2veDAcZe4o22uvXg7ItXIj+OMswVadzTpv7GCq76TEMYm9/nPjqmR1KWdzEfUHHEFMKpGdImBq1wnlE6ipPlsLt6IzBBjENdMOaG8bQ5FycYTxdGJVx7lDOg+BQG+d7uFJ50PURatt/znnp4G4xZuzNxaT81Ag36jnWVD39S3VLSOEaqB08js7mk4etHBU7Hk1AGIOJoDsUHU2zu99MCl6DP9l1;jHS91a49OmBW3C626dzlxg=="
---

